back to US directory
us clinical guidance

Chronic insomnia disorder assessment and treatment

VA/DoD-aligned clinical diagnosis, CBT-I first-line care, selective sleep testing and medication safety review.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with sleep-initiation or sleep-maintenance difficulty and daytime consequences despite adequate opportunity for sleep. The 2025 VA/DoD guideline defines chronic insomnia around symptoms occurring at least three times weekly for more than three months. Shift-work disorder, parasomnia, narcolepsy, acute crisis and pediatric sleep disorders require different pathways.
sources for this section:VA/DoD insomnia 2025

The Bottom Line

  • Diagnose chronic insomnia clinically from sleep, medical and psychiatric history; questionnaires can support screening and follow-up but do not replace the interview.
  • Offer cognitive behavioral therapy for insomnia as first-line treatment and consider brief behavioral treatment when full CBT-I is not available or feasible.
  • Do not use sleep-hygiene education alone as adequate treatment; combine behavioral components that address sleep scheduling, conditioned arousal and unhelpful sleep beliefs.
  • Reserve polysomnography or other objective testing for suspected obstructive sleep apnea, movement disorder, parasomnia or another sleep diagnosis rather than routine confirmation of insomnia.
sources for this section:VA/DoD insomnia 2025

Practical clinical workflow

1
Clarify timing, duration, schedule, opportunity, daytime effects, naps, substances, medications, pain, menopause, mood, trauma and prior sleep treatment, using a sleep diary when helpful.
2
Screen for snoring, witnessed apnea, sleepiness, restless legs, circadian misalignment, parasomnia, mania, depression, substance use and environmental or caregiving disruption.
3
Arrange CBT-I or brief behavioral therapy, agree on functional goals and provide realistic expectations about early sleep restriction or stimulus-control challenges with appropriate monitoring.
4
If medication is considered, make it an individualized, time-bounded shared decision, review interaction and fall risk and reassess efficacy, daytime function and ongoing need rather than renewing automatically.
sources for this section:VA/DoD insomnia 2025

Safety boundaries and escalation

  • Dangerous sleepiness while driving or operating equipment, suspected severe sleep apnea, nocturnal hypoventilation, mania, psychosis or acute suicidal thinking requires prompt escalation.
  • Avoid combining sedative-hypnotics with alcohol, opioids or other central nervous system depressants without a compelling, explicitly monitored rationale because impairment and respiratory risk can compound.
  • Older adults, pregnant patients and people with falls, cognitive impairment, respiratory disease, liver disease or substance-use history require additional medication caution.
  • Complex sleep behavior, severe next-day impairment, paradoxical agitation or worsening mood after a hypnotic requires immediate medication review and may require discontinuation under product labeling.
sources for this section:VA/DoD insomnia 2025

Localization

The 2025 VA/DoD guideline is a current US federal framework and strongly centers CBT-I. US behavioral-sleep access, digital-CBT coverage, controlled-substance law and payer formularies vary.
sources for this section:VA/DoD insomnia 2025

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea2025 guideline 路 published 2025-01-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.